Insider Transactions in Q2 2024 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 26
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
2,500
+50.0%
|
-
|
Jun 26
2024
|
Vickie L Capps |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.54%
|
-
|
Jun 26
2024
|
Jake Simson |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Jun 26
2024
|
Ronald W Barrett |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Jun 26
2024
|
Sheila Gujrathi |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+2.21%
|
-
|
Jun 26
2024
|
Winston Kung |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Jun 26
2024
|
Alana B. Mc Nulty |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Jun 26
2024
|
Jay Lichter |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+26.09%
|
-
|
Jun 03
2024
|
Jay Lichter |
SELL
Open market or private sale
|
Indirect |
1,500,000
-17.15%
|
$81,000,000
$54.75 P/Share
|
Jun 03
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
822,721
-17.15%
|
$44,426,934
$54.75 P/Share
|
Jun 03
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
677,279
-17.15%
|
$36,573,066
$54.75 P/Share
|
Jun 03
2024
|
Tighe Reardon Acting Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
822,721
-17.15%
|
$44,426,934
$54.75 P/Share
|